Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5834448 | BTG INTL | Dosage form of hydroxocobalamin and its use in cyanide poisoning |
Nov, 2016
(7 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity(ODE) | Dec 15, 2013 |
Market Authorisation Date: 15 December, 2006
Treatment: NA
Dosage: INJECTABLE;INJECTION